Venous thromboembolism risk was unaffected in women who received postpartum implants before discharge.
Women face dramatically increased risk for venous thromboembolism (VTE) for up to 3 months postpartum. To evaluate whether immediate postpartum placement of a contraceptive implant (the most effective form of contraception available) affects women's risk for VTE, researchers analyzed data from the U.S. Nationwide Readmissions Database on >3 million women with a singleton delivery in 2016.
Of 8369 women who had a contraceptive implant placed prior to hospital discharge, 7 were readmitted for VTE within 30 days of delivery. After adjusting for smoking, hypertension, peripartum infection, and postpartum hemorrhage, rates of readmission for VTE were not significantly higher among those who received an immediate postpartum implant (odds ratio, 1.…
Reviewing Author
DisclosuresConsultant/Advisory BoardPlanned Parenthood Federation of America
Grant/Research SupportSociety of Family Planning; California Department of Public Health Tobacco Control Program
Editorial BoardsContraception; Journal of General Internal Medicine
Leadership Positions in Professional SocietiesCouncil Member, Society of General Internal Medicine
DisclosuresConsultant/Advisory BoardPlanned Parenthood Federation of America
Grant/Research SupportSociety of Family Planning; California Department of Public Health Tobacco Control Program
Editorial BoardsContraception; Journal of General Internal Medicine
Leadership Positions in Professional SocietiesCouncil Member, Society of General Internal Medicine